Lin Li

发表

EphA2 recognizes Dermatophagoidespteronyssinus to mediate airway inflammation in asthma.

Wenfeng Xu, Qing Yuan, Xiyuan Guo, 2022, International immunopharmacology.

Changes in the phenotype and function of mucosal-associated invariant T cells in neutrophilic asthma.

Qing Yuan, Peng Kang, Song-Quan Wang, 2022, International immunopharmacology.

Fully human recombinant antibodies against EphA2 from a multi-tumor patient immune library suitable for tumor-targeted therapy

Qing Yuan, Qing Liu, Bo Zhang, 2021, Bioengineered.

Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer

Bo Zhang, Wenfeng Xu, Qing Yuan, 2022, Journal of Cancer Research and Clinical Oncology.

Steroidal saponins with anti-inflammatory activity from Tribulus terrestris L.

P. Zhang, Shijie Cao, Pengzhi Dong, 2022, Acupuncture and Herbal Medicine.

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma

Qing Yuan, Xueyuan Huang, Xiyuan Guo, 2023, Genes.

The onset, development and pathogenesis of severe neutrophilic asthma

Qing Yuan, Xiyuan Guo, Xingli Zhang, 2022, Immunology and cell biology.

Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade.

Sheng Lin, Qing Yuan, Q. Jiang, 2023, Cytokine.

Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker

Qing Yuan, Xiyuan Guo, Yaqi Yang, 2022, Scientific Reports.

Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker

Qing Yuan, Xiyuan Guo, Yaqi Yang, 2022, Journal of oncology.

EphA2 recognizes Dermatophagoidespteronyssinus to mediate airway inflammation in asthma.

Wenfeng Xu, Qing Yuan, Xiyuan Guo, 2022, International immunopharmacology.